HOMA-IR as a risk factor of gestational diabetes mellitus and a novel simple surrogate index in early pregnancy
- PMID: 34449903
- DOI: 10.1002/ijgo.13905
HOMA-IR as a risk factor of gestational diabetes mellitus and a novel simple surrogate index in early pregnancy
Abstract
Objective: To assess the association between insulin resistance and gestational diabetes mellitus (GDM) in early pregnancy and find a simple surrogate index of the homeostasis model assessment of insulin resistance (HOMA-IR).
Methods: A total of 700 pregnant women were included in this prospective, double-center, observational cohort study. The glucose and lipid metabolic characterization was performed at 6-12 weeks of pregnancy. All participants underwent a 75-g oral glucose tolerance test at 24-28 weeks of pregnancy. Linear regression analysis was applied to find a novel surrogate index of HOMA-IR. Binary logistic analysis was applied to estimate possible associations of different indices with GDM and insulin resistance.
Results: GDM was diagnosed in 145 of 700 women with singleton pregnancies (20.7%). HOMA-IR was higher in the GDM group than in the normal glucose tolerance (NGT) group and was an individual risk factor for GDM (adjusted risk ratio RR 1.371, 95% confidence interval [CI] 1.129-1.665, P < 0.001). TyHGB index as the surrogate index of HOMA-IR was represented as TG/HDL-C + 0.7*FBG (mmol/L) +0.1*preBMI (kg/m2 )(where TG/HDL-C is triglyceride/high-density lipoprotein cholesterol; FBG is fasting blood glucose, and preBMI is the pre-pregnancy body mass index [calculated as weight in kilograms divided by the square of height in meters]). The cut-off point of the TyHGB index was 6.0 (area under the curve 0.827, 95% CI 0.794-0.861, P < 0.001) for mild insulin resistance.
Conclusion: Increased HOMA-IR in early pregnancy was a risk factor of GDM. TyHGB index could be a surrogate index of HOMA-IR and had a predictive value for GDM.
Keywords: HOMA-IR; gestational diabetes mellitus; glucose and lipid metabolism; insulin resistance.
© 2021 International Federation of Gynecology and Obstetrics.
Similar articles
-
Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5702-5710. doi: 10.26355/eurrev_201712_14016. Eur Rev Med Pharmacol Sci. 2017. PMID: 29272006
-
The yield of early-pregnancy homeostasis of model assessment -insulin resistance (HOMA-IR) for predicting gestational diabetes mellitus in different body mass index and age groups.BMC Pregnancy Childbirth. 2023 Nov 28;23(1):822. doi: 10.1186/s12884-023-06113-3. BMC Pregnancy Childbirth. 2023. PMID: 38017369 Free PMC article.
-
[Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].Zhonghua Fu Chan Ke Za Zhi. 2014 Aug;49(8):584-7. Zhonghua Fu Chan Ke Za Zhi. 2014. PMID: 25354858 Chinese.
-
The Effects of Probiotics/Synbiotics on Glucose and Lipid Metabolism in Women with Gestational Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.Nutrients. 2023 Mar 12;15(6):1375. doi: 10.3390/nu15061375. Nutrients. 2023. PMID: 36986107 Free PMC article. Review.
-
Effect of Probiotics on Metabolic Outcomes in Pregnant Women with Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Nutrients. 2017 May 5;9(5):461. doi: 10.3390/nu9050461. Nutrients. 2017. PMID: 28475161 Free PMC article. Review.
Cited by
-
Maternal inflammatory, lipid and metabolic markers and associations with birth and breastfeeding outcomes.Front Nutr. 2023 Sep 4;10:1223753. doi: 10.3389/fnut.2023.1223753. eCollection 2023. Front Nutr. 2023. PMID: 37731394 Free PMC article.
-
Energy-Adjusted Dietary Inflammatory Index in pregnancy and maternal cardiometabolic health: findings from the ROLO study.AJOG Glob Rep. 2023 Apr 24;3(2):100214. doi: 10.1016/j.xagr.2023.100214. eCollection 2023 May. AJOG Glob Rep. 2023. PMID: 37234814 Free PMC article.
-
Assessment of serum biotin levels and its association with blood glucose in gestational diabetes mellitus.Eur J Obstet Gynecol Reprod Biol X. 2023 Feb 17;17:100181. doi: 10.1016/j.eurox.2023.100181. eCollection 2023 Mar. Eur J Obstet Gynecol Reprod Biol X. 2023. PMID: 36873578 Free PMC article.
-
Longitudinal trends in lipid profiles during pregnancy: Association with gestational diabetes mellitus and longitudinal trends in insulin indices.Front Endocrinol (Lausanne). 2023 Jan 13;13:1080633. doi: 10.3389/fendo.2022.1080633. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36714591 Free PMC article.
-
Predictability of HOMA-IR for Gestational Diabetes Mellitus in Early Pregnancy Based on Different First Trimester BMI Values.J Pers Med. 2022 Dec 28;13(1):60. doi: 10.3390/jpm13010060. J Pers Med. 2022. PMID: 36675721 Free PMC article.
References
REFERENCES
-
- Landon MB, Gabbe SG. Gestational diabetes mellitus. Obstet Gynecol. 2011;118(6):1379-1393.
-
- Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016;16(1):7.
-
- Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016;59(7):1396-1399.
-
- Lacroix M, Kina E, Hivert MF. Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life. Curr Diab Rep. 2013;13(2):238-244.
-
- Temming LA, Tuuli MG, Stout MJ, Macones GA, Cahill AG. Maternal and perinatal outcomes in women with insulin resistance. Am J Perinatol. 2016;33(8):776-780.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
